Daphne Day

14PUBLICATIONS
34CO-AUTHORS
Implementation science and evaluationMolecular targetsCancer geneticsCultural theoryMedical genetics (excl. cancer genetics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 14, 2026
Leveraging Real-World Evidence to Drive Advances in Oncology Care in the Asia-Pacific Region: Recommendations From the Asia-Pacific Oncology Drug Development Consortium Working Group.

|Apr 15, 2025
First-in-human phase I study of EMB-02, a bispecific antibody targeting PD-1 and LAG-3 in patients with advanced solid tumors.

Daphne Day, Vinod Ganju, Ki Chung

|Aug 28, 2024
Equitable Access to Genomic Molecular Testing for Australian Cancer Patients: Insights from the Victorian Precision Oncology Summit.

Genevieve Dall, Karen Harris, Nonie Chan

|Jun 27, 2024
COVID-19 Vaccine Acceptance, Hesitancy, and Uptake in People with Diabetes in Australia.

Holly Wang, Lisa Grech, Jennifer Wong

|Sep 21, 2023
A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer.

Daphne Day, John J Park, Jermaine Coward

|Jun 26, 2023
Operational Challenges of an Asia-Pacific Academic Oncology Clinical Trial.

Daphne Day, Han Chong Toh, Raghib Ali

Pageof 3

Frequent Collaborators

8 joint publications

Eva Segelov

4 joint publications

Mike Nguyen

4 joint publications

Kate Webber

3 joint publications

Lisa Grech